These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32021072)
1. Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy. Brooks CC; Jabbehdari S; Gupta PK Clin Ophthalmol; 2020; 14():89-94. PubMed ID: 32021072 [TBL] [Abstract][Full Text] [Related]
2. Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis. Foster B Clin Ophthalmol; 2021; 15():4091-4096. PubMed ID: 34703199 [TBL] [Abstract][Full Text] [Related]
3. Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation. Lee A; Blair HA Drugs; 2020 Jul; 80(11):1101-1108. PubMed ID: 32588339 [TBL] [Abstract][Full Text] [Related]
4. Retrospective Study of a Sustained-Release Intracanalicular Dexamethasone Insert for Treatment of Ocular Inflammation After Cataract and Corneal Surgery. Fram N; Alsetri H; Shiler O; Paterno PJ; Cabang J Clin Ophthalmol; 2022; 16():4065-4074. PubMed ID: 36532822 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy. Suñer IJ; Peden MC Clin Ophthalmol; 2021; 15():3859-3864. PubMed ID: 34556974 [TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. Tyson SL; Bafna S; Gira JP; Goldberg DF; Jones JJ; Jones MP; Kim JK; Martel JM; Nordlund ML; Piovanetti-Perez IK; Singh IP; Metzinger JL; Mulani D; Sane S; Talamo JH; Goldstein MH; J Cataract Refract Surg; 2019 Feb; 45(2):204-212. PubMed ID: 30367938 [TBL] [Abstract][Full Text] [Related]
7. A sustained-release intracanalicular dexamethasone insert (Dextenza) for pediatric cataract surgery. Trivedi RH; Wilson ME J AAPOS; 2021 Feb; 25(1):43-45. PubMed ID: 33321213 [TBL] [Abstract][Full Text] [Related]
9. Comparing Intracanalicular and Topical Steroid Use in Patients Undergoing Pterygium Surgery. Rhee MK; Zakher M; Najac M; Arias H; Jo J; Gorham R; Moadel K Eye Contact Lens; 2024 Apr; 50(4):183-188. PubMed ID: 38305478 [TBL] [Abstract][Full Text] [Related]
10. In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study. Ibach MJ; Zimprich L; Wallin DD; Olevson C; Puls-Boever K; Thompson V Clin Ophthalmol; 2022; 16():2609-2615. PubMed ID: 35992569 [TBL] [Abstract][Full Text] [Related]
11. A Randomized, Controlled, Prospective Study of the Effectiveness and Safety of an Intracanalicular Dexamethasone Ophthalmic Insert (0.4 Mg) for the Treatment of Post-Operative Inflammation in Patients Undergoing Refractive Lens Exchange (RLE). Larsen J; Whitt T; Parker B; Swan R Clin Ophthalmol; 2021; 15():2211-2217. PubMed ID: 34079218 [TBL] [Abstract][Full Text] [Related]
12. Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model. Torkildsen G; Abelson MB; Gomes PJ; McLaurin E; Potts SL; Mah FS J Ocul Pharmacol Ther; 2017 Mar; 33(2):79-90. PubMed ID: 28072552 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery. Saenz B; Ferguson TJ; Abraham N; Mueller BH; Parkhurst GD Clin Ophthalmol; 2021; 15():4615-4620. PubMed ID: 34916773 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey. Gira JP; Sampson R; Silverstein SM; Walters TR; Metzinger JL; Talamo JH Patient Prefer Adherence; 2017; 11():487-494. PubMed ID: 28331295 [TBL] [Abstract][Full Text] [Related]
15. Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults. Blizzard C; McLaurin EB; Driscoll A; Silva FQ; Vantipalli S; Metzinger JL; Goldstein MH Clin Ophthalmol; 2021; 15():2055-2061. PubMed ID: 34040341 [TBL] [Abstract][Full Text] [Related]
16. Toxicity and Pharmacokinetics of Sustained-Release Dexamethasone in Beagle Dogs. Driscoll A; Blizzard C Adv Ther; 2016 Jan; 33(1):58-67. PubMed ID: 26733409 [TBL] [Abstract][Full Text] [Related]
17. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery. Walters T; Endl M; Elmer TR; Levenson J; Majmudar P; Masket S J Cataract Refract Surg; 2015 Oct; 41(10):2049-59. PubMed ID: 26703279 [TBL] [Abstract][Full Text] [Related]
18. Correction to: Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation. Lee A; Blair HA Drugs; 2020 Aug; 80(12):1265. PubMed ID: 32700064 [TBL] [Abstract][Full Text] [Related]